Skip to main content

Table 1 Comparison of clinical baseline data between two groups

From: Epicardial Adipose Tissue and Heterogeneity Parameters Combined with Inflammatory Cells to Predict the Value of Heart Failure with Preserved Ejection Fraction Patients Post Myocardial Infarction

Parameters

Total (n = 203)

No-HFpEF (n = 129)

HFpEF (n = 74)

χ2/t/Z value

P value

Male [n(%)]

148 (73.40)

97 (75.19)

51 (68.92)

0.937

0.333

Age (years)

55.13 ± 13.17

53.81 ± 13.622

57.45 ± 12.09

1.908

0.058

BMI (kg/m2)

23.70 (21.90, 26.20)

23.40 (21.60, 25.55)

24.40(22.23, 26.73)

− 1.986

0.047*

Smoke [n (%)]

92 (45.32)

56 (43.41)

36 (48.65)

0.521

0.471

Hypertension [n (%)]

114 (56.16)

70 (54.26)

44 (59.46)

0.158

0.166

Diabetes [n (%)]

56 (27.59)

27 (20.93)

29 (39.19)

7.848

0.005*

Systolic pressure (mmHg)

130.00 ± 21.47

130.32 ± 21.68

129.46 ± 21.24

− 0.273

0.785

Diastolic pressure (mmHg)

80.66 ± 14.53

80.77 ± 13.98

80.47 ± 15.54

− 0.139

0.890

Pulse pressure (mmHg)

47.00 (39.00, 58.00)

46.00 (38.50, 56.50)

47.00 (39.75, 59.00)

− 0.283

0.777

NYHA

   

5.952

0.051

I

120 (59.11)

77 (59.69)

43 (58.11)

  

II

77 (37.93)

51 (39.53)

26 (5.13)

  

III

6 (2.96)

1 (0.78)

5 (6.76)

  

Renal failure [n (%)]

10 (4.93)

3 (2.33)

7 (9.46)

5.110

0.024*

LDL (mmol/L)

2.37 (1.86, 3.18)

2.37 (1.87, 3.17)

2.29 (1.86, 3.20)

− 0.567

0.571

HDL (mmol/L)

1.11 (0.94, 1.24)

1.10 (0.95, 1.26)

1.13 (0.92, 1.20)

− 0.562

0.574

TC (mmol/L)

4.04 (3.33, 4.88)

4.03 (3.35, 4.88)

4.10 (3.23, 4.92)

0.528

0.598

TG (mmol/L)

1.56 (1.12, 2.24)

1.63 (1.20, 2.40)

1.40 (0.86, 2.05)

− 2.105

0.035*

NHR

0.22 (0.16, 0.28)

0.21 (0.16, 0.27)

0.24 (0.17, 0.34)

− 2.582

0.010*

MHR

0.02 (0.02, 0.03)

0.02 (0.02, 0.03)

0.03 (0.02, 0.04)

− 2.223

0.026*

LHR

0.09 (0.07, 0.12)

0.09 (0.06, 0.12)

0.10 (0.07, 0.14)

− 1.752

0.080

NLR

2.31 (1.78, 3.23)

2.22 (1.78, 3.07)

2.50 (1.75, 3.50)

− 1.059

0.290

SIRI

1.05 (0.75, 1.64)

1.02 (0.73, 1.46)

1.20 (0.81, 1.96)

− 1.804

0.071

White blood cell (10*9/L)

7.18 (6.01, 8.33)

7.12 (5.96, 7.95)

7.38 (6.15, 9.02)

− 2.256

0.024*

Neutrophils (10*9/L)

4.20 (3.34, 5.26)

4.06 (3.22, 4.81)

4.58 (3.59, 5.77)

− 2.494

0.013*

Lymphocyte (10*9/L)

1.82 (1.37, 2.25)

1.80 (1.34, 2.19)

1.84 (1.40, 2.35)

− 1.251

0.211

Monocyte (10*9/L)

0.46 (0.37, 0.57)

0.45 (0.37, 0.53)

0.51 (0.38, 0.65)

− 2.176

0.030*

Eosinophils (10*9/L)

0.12 (0.07, 0.20)

0.12 (0.07, 0.22)

0.11 (0.58, 0.17)

− 1.835

0.067

Basophil granulocyte (10*9/L)

0.02 (0.02, 0.04)

0.02 (0.02, 0.04)

0.02 (0.01, 0.03)

− 1.109

0.268

Red blood cell (10*9/L)

4.84 (4.46, 5.24)

4.82 (4.45, 5.24)

4.86 (4.50, 5.24)

− 0.236

0.814

Urea (mmol/L)

4.93 (4.16, 6.10)

4.88 (4.05, 5.87)

5.24 (4.37, 6.36)

− 1.255

0.210

Creatinine (µmol/L)

78.00 (68.00, 92.00)

77.00 (68.00, 90.50)

80.00 (66.50, 93.00)

− 0.651

0.515

Total EAT (mL)

64.82 ± 20.65

62.18 ± 19.93

69.43 ± 21.21

2.437

0.016*

EAT/BSA

37.68 (26.95, 46.72)

37.50 (26.21, 45.94)

39.48 (29.78, 50.48)

− 1.631

0.103

LV EAT (mL)

22.62 ± 8.02

21.37 ± 8.13

24.81 ± 7.39

3.003

0.003*

RV EAT (mL)

42.20 ± 14.27

40.81 ± 13.68

44.61 ± 15.03

1.838

0.068

EAT entropy

6.53 (6.25, 7.03)

6.75 (6.26, 7.15)

6.40 (6.22, 6.86)

− 2.242

0.025*

LVEF (%)

60.00 (52.00, 65.00)

62.00 (47.50, 67.00)

57.50 (55.00, 63.00)

− 1.173

0.241

LADSV (mL)

27.11 (18.42, 37.56)

26.24 (17.97, 36.75)

29.14 (21.18, 40.83)

− 1.654

0.100

LAESV(mL)

53.18 (40.42, 67.38)

51.24 (39.46, 64.44)

56.18 (42.13, 73.00)

− 2.033

0.042*

EDVI(mL/m2)

75.09 (61.53, 93.83)

75.88 (61.18, 94.33)

74.72 (61.32, 93.31)

− 0.159

0.874

ESVI(mL/m2)

36.09 (25.76, 55.56)

35.35 (23.69, 57.58)

38.23 (29.90, 52.71)

− 0.997

0.319

LACI(%)

19.65 (15.24, 28.28)

19.23(15.19,26.29)

23.45 (15.49, 33.42)

− 2.316

0.021*

CO(L/min)

4.29 ± 1.52

4.25 ± 1.46

4.35 ± 1.62

0.436

0.663

CI (L/(min m2))

2.50 (1.98, 3.07)

2.48 (1.99, 3.05)

2.57 (1.91, 3.08)

− 0.309

0.757

IS(%)

13.72 (7.02, 20.50)

13.45 (5.73, 20.88)

13.78 (9.20, 20.15)

− 0.443

0.658

GRS(%)

23.33 (16.97, 30.38)

24.60 (16.55, 30.14)

22.23 (17.92, 31.17)

− 0.592

0.554

GCS(%)

− 16.0 6(− 18.74, − 12.08)

− 16.38 (− 19.24, − 10.98)

− 15.84 (− 17.92, − 13.55)

− 0.216

0.829

GLS(%)

− 11.15 ± 3.69

− 11.04 ± 3.94

− 11.34 ± 3.23

− 0.571

0.568

Mitral regurgitation [n (%)]

   

3.587

0.310

No

75 (36.95)

53 (41.09)

22 (29.73)

  

Little

21 (10.34)

12 (9.30)

9 (12.16)

  

Mild

100 (49.26)

61 (47.29)

39 (52.70)

  

Moderate

7 (3.45)

3 (2.33)

4 (5.41)

  

Tricuspid regurgitation [n (%)]

   

3.247

0.355

No

79 (38.92)

53 (41.09)

26 (35.14)

  

Little

14 (6.90)

8 (6.20)

6 (8.11)

  

Mild

106 (52.22)

67 (51.94)

39 (52.70)

  

Moderate

4 (1.97)

1 (0.78)

3 (4.05)

  

Aortic regurgitation [n (%)]

   

0.850

0.838

No

125 (61.58)

81 (62.79)

44 (59.46)

  

Little

38 (18.72)

22 (17.05)

16 (21.62)

  

Mild

38 (18.72)

25 (19.38)

13 (17.57)

  

Moderate

2 (0.99)

1 (0.78)

1 (1.35)

  

Pulmonary hypertension [n (%)]

18 (8.87)

9 (6.98)

9(12.16)

1.565

0.211

Pathological vascular branch [n (%)]

   

7.445

0.059

0

24 (11.82)

19 (14.73)

5 (6.76)

  

1

112 (55.17)

75 (58.14)

37 (50.00)

  

2

51 (25.12)

28 (21.71)

23 (31.08)

  

3

16 (7.88)

7 (5.43)

9 (12.16)

  

Pathological vascular [n (%)]

     

LAD

123 (60.59)

74 (57.36)

49 (66.22)

1.543

0.214

LCX

69 (33.99)

39 (30.23)

30 (40.54)

2.227

0.136

RCA

70 (34.49)

39 (30.23)

31 (41.89)

2.830

0.093

β-blockers [n (%)]

179 (88.18)

112 (86.82)

67 (90.54)

0.624

0.430

ARNI [n (%)]

59 (29.06)

35 (27.13)

24 (32.43)

0.641

0.423

ACEI [n (%)]

65 (32.02)

37 (28.68)

28 (37.84)

1.811

0.178

ARB [n (%)]

27 (13.31)

18 (13.95)

9 (12.16)

0.131

0.718

Statins [n (%)]

189 (93.10)

118 (91.47)

71 (95.95)

1.465

0.226

Diuretics [n (%)]

63 (31.03)

38 (29.46)

25 (33.78)

0.411

0.521

ASA [n (%)]

173 (85.22)

111 (86.05)

62 (83.78)

0.191

0.662

CLO [n (%)]

129 (63.55)

82 (63.57)

47 (63.51)

0.000

0.994

TMZ [n (%)]

82 (40.39)

51 (39.53)

31 (41.89)

0.109

0.742

DIG [n (%)]

16 (7.88)

10 (7.75)

6 (8.12)

0.008

0.928

  1. BMI body mass index, NYHA New York Heart Association, LDL low-density lipoprotein, HDL high-density lipoprotein cholesterol, TC total cholesterol, TG triglyceride, NHR Neutrophil/high-density lipoprotein cholesterol ratio, MHR mononuclear cell/high-density lipoprotein cholesterol ratio, LHR lymphocyte/high-density lipoprotein cholesterol ratio, NLR neutrophils/lymphocytes ratio, SIRI systemic immune-inflammation index, EAT epicardial adipose tissue, LV left ventricular, RV right ventricular, BSA body surface area, LVEF left ventricular ejection fraction, LADSV left atrial diastolic-systolic volume, LAESV left atrial end-systolic volume, EDVI end diastolic volume index, ESVI end systolic volume index, LACI left atrial-ventricular coupling index, CO cardiac output, CI cardiac index, IS infarct size, GRS global radial strain, GCS global circumferential strain, GLS global longitudinal strain, LAD left anterior descending artery, LCX left circumflex, RCA right coronary artery, ARNI angiotensin receptor-neprilysin inhibitor, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blockers, ASA aspirin, CLO Cloxicillin, TMZ temozolomide, DIG digoxin